Friday, October 28, 2022 Daily Archives

Lonza to expand US and EU CGT lab space

by

Lonza will expand its cell and gene therapy (CGT) development laboratories in the US at its Houston, Texas facility and in Europe at its plant in Geleen, The Netherlands. Swiss contract development manufacturing organization (CDMO) Lonza says the expansion in Houston will include viral vector-based process development and analytical development laboratories. In addition to its Houston expansion, the firm claims it will more than double its European process development laboratory space in Geleen, The Netherlands. The CDMO will add 4,500…

October 28, 2022

CMO initial offering: Adding an ‘R’ or ‘T’ blurs message, says marketing expert

by

The ‘D’ for ‘Development’ has become standard among the nomenclature of contract manufacturing organizations (CMOs) but the addition of an ‘R’ for ‘Research’ or ‘T’ for ‘Testing’ is needless and confusing, says marketing specialist Raman Sehgal. It sounds like the start of a joke, but what do you call a collection of biopharma manufacturing service firms? ‘Suppliers’ is too vague; ‘Third-party manufacturers’ is too clunky; CRAMS (Contract Research and Manufacturing Services), meanwhile, has not been used outside of Asia since…

October 28, 2022

Landmark Bio opens advanced therapy manufacturing plant in MA

by

Academia-industry joint venture firm Landmark Bio says the recently opened Watertown, Massachusetts facility offers a one-stop-shop for manufacturing solutions. Harvard University, MIT, Fujifilm Diosynth Biotechnologies, Alexandria Real Estate Equities, and Cytiva – the founders of Landmark Bio – collectively invested $75 million to support construction staff and early client services for the 44,000 square-foot Watertown facility that will carry out development, manufacturing, and testing of cell and gene therapies in the area. Other collaborating institutions include Beth Israel Deaconess Medical…

October 28, 2022